maglobin.

CBOE FILES FOR FIRST-EVER STAKED INJECTIVE ETF IN U.S. - Cboe BZX filed to list an ETF that tracks staked INJ—the native token of the @Injective blockchain. - Filed on behalf of hedge fund Canary Capital Group, the ETF would offer exposure to Injective while generating staking rewards. - The proposed product, called the Canary Staked INJ ETF, could become the first regulated U.S. ETF tied to a staked Layer-1 asset. - It would also mark a first for Injective, a blockchain designed specifically for decentralized finance. What sets this ETF apart? - Unlike most crypto funds, this one would actively participate in Injective’s proof-of-stake system. That means holders earn staking rewards—without dealing with wallets, validators, or lock-ups. - This structure simplifies access to staking-based yield for traditional investors. It lowers technical barriers while preserving regulatory compliance. - On the same day, Cboe also filed for a Solana ETF in partnership with Invesco and Galaxy. The filings come amid rising optimism that more crypto ETFs could clear U.S. regulators under the new administration.